puromycin and nitazoxanide

A high-content imaging assay was used to screen the fraction collection of the Natural Product Library at The Scripps Research Institute for inhibitors of Cryptosporidium parvum. A chemical investigation of one strain, Streptomyces sp. CB01388, resulted in the isolation of six herbicidins (1-6), one of which is new (herbicidin L, 1). Five of the six herbicidins (1-3, 5, 6) showed moderate inhibitory activity against C. parvum, with 1 and 6 comparable to the FDA-approved drug nitazoxanide, and 2-6 showed no toxicity to the host HCT-8 cells and human HEK293T and HepG2 cells. These findings highlight the herbicidin scaffold for anti- Cryptosporidium drug development.

Topics: Anti-Bacterial Agents; Biological Products; Cell Line; Cell Line, Tumor; Cryptosporidium parvum; HEK293 Cells; Hep G2 Cells; Humans; Nitro Compounds; Purine Nucleosides; Streptomyces; Thiazoles